微小RNA在肺癌干细胞中的调控作用

国际肿瘤学杂志››2019,Vol. 46››Issue (4): 231-234.doi:10.3760/cma.j.issn.1673-422X.2019.04.008

微小RNA在肺癌干细胞中的调控作用

赵国丽^1，2,刘恒铫¹,张月英²

¹济南大学 betway.com 医学与生命科学学院 250200；²betway.com 基础医学研究所病理学与病理生理学研究室，济南 250062

收稿日期:2019-01-07修回日期:2019-02-27出版日期:2019-04-08发布日期:2019-05-29
通讯作者:张月英，Email: zhangyueying828@126.com E-mail:zhangyueying828@126.com
基金资助:

国家自然科学基金（81403150）；山东省自然科学基金（ZR2014HL064）；山东省中医药科技发展项目（2015-325）；betway.com 医药卫生科技创新工程

Regulating effect of microRNAs in lung cancer stem cells

Zhao Guoli^1,2, Liu Hengyao¹, Zhang Yueying²

¹School of Medicine and Life Sciences, University of JinanShandong Academy of Medical Sciences, Jinan 250200, China;²Laboratory of Pathology and Pathophysiology, Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences, Jinan 250062, China

Received:2019-01-07Revised:2019-02-27Online:2019-04-08Published:2019-05-29
Contact:Zhang Yueying, Email: zhangyueying828@126.com E-mail:zhangyueying828@126.com
Supported by:

National Natural Science Foundation of China (81403150); Natural Science Foundation of Shandong Province of China (ZR2014HL064); Development Project of Traditional Chinese Medical Sciences and Technology of Shandong Province of China (2015-325); Innovation Project of Shandong Academy of Medical Sciences

摘要/Abstract

摘要：肺癌干细胞在肺癌的化疗耐药以及侵袭转移中发挥着重要作用。越来越多的证据表明，微小RNA（miRNA）在肿瘤血管生成、耐药性和转移的调节中扮演着重要角色。鉴于肿瘤干细胞被认为是导致肿瘤复发、转移和化疗耐药的原因之一，因此更好地理解miRNA如何调节肺癌干细胞中的基因表达有助于识别新的肿瘤生物标志物和治疗靶点，并将有助于制定更好的肺癌治疗策略。

赵国丽1，2,刘恒铫1,张月英2 . 微小RNA在肺癌干细胞中的调控作用[J]. 国际肿瘤学杂志, 2019, 46(4): 231-234.

Zhao Guoli1,2, Liu Hengyao1, Zhang Yueying2. Regulating effect of microRNAs in lung cancer stem cells[J]. Journal of International Oncology, 2019, 46(4): 231-234.

［1］ Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018［J］. CA Cancer J Clin, 2018, 68(1): 7-30. DOI: 10.3322/caac.21442. ［2］ Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice［J］. Nature, 1994, 367(6464): 645-648. DOI: 10.1038/367645a0. ［3］ Li L, Li JC, Yang H, et al. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis［J］. Proc Natl Acad Sci U S A, 2018, 115(38): 8948-8957. DOI: 10.1073/pnas.1806219115. ［4］ Yu Y, Wang YY, Wang YQ, et al. Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia［J］. Sci Rep, 2016, 6: 34239. DOI: 10.1038/srep34239. ［5］ Suresh R, Ali S, Ahmad A, et al. The role of cancer stem cells in recurrent and drug-resistant lung cancer［J］. Adv Exp Med Biol, 2016, 890: 57-74. DOI: 10.1007/978-3-319-24932-2_4. ［6］ Lin S, Sun JG, Wu JB, et al. Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549［J］. Mol Cells, 2012, 33(3): 277-283. DOI: 10.1007/s10059-012-2252-y. ［7］ Sun X, Jiao X, Pestell TG, et al. MicroRNAs and cancer stem cells: the sword and the shield［J］. Oncogene, 2014, 33(42): 4967-4977. DOI: 10.1038/onc.2013.492. ［8］ Zhang F, Li T, Han L, et al. TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells［J］. Biochem Biophys Res Commun, 2018, 496(4): 1169-1175. DOI: 10.1016/j.bbrc.2018.01.164. ［9］米永华, 何苗, 刘北忠. miR-133b靶向PKM2基因对肺癌A549干细胞增殖及药物敏感性的影响［J］. 中国肺癌杂志, 2017, 20(6): 376-381. DOI: 10.3779/j.issn.1009-3419.2017.06.02. ［10］ Chiou GY, Cherng JY, Hsu HS, et al. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma［J］. J Control Release, 2012, 159(2): 240-250. DOI: 10.1016/j.jconrel.2012.01.014. ［11］ Zhu J, Wang S, Chen Y, et al. miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells［J］. J Nutr Biochem, 2017, 44: 80-91. DOI: 10.1016/j.jnutbio.2017.02.020. ［12］ Shi L, Wang Y, Lu Z, et al. miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop［J］. Oncogene, 2017, 36(12): 1631-1643. DOI: 10.1038/onc.2016.332. ［13］ Jiang HL, Jiang LM, Han WD. Wnt/βcatenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs［J］. J BUON, 2015, 20(4): 1094-1100. ［14］ Gong L, Song J, Lin X. Serinearginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC［J］. J Pathol, 2016, 240(2): 184-196. DOI: 10.1002/path.4767. ［15］ Zhu J, Jiang Y, Yang X, et al. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells［J］. Biochem Biophys Res Commun, 2017, 482(1): 15-21. DOI: 10.1016/j.bbrc.2016.11.038. ［16］ Fang L, Cai J, Chen B, et al. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signaling［J］. Nat Commun, 2015, 6: 8640. DOI: 10.1038/ncomms9640. ［17］ Xu W, Ji J, Xu Y, et al. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformedhuman bronchial epithelial cells［J］. Mol Carcinog, 2015, 54 Suppl 1: E148-E161. DOI: 10.1002/mc.22221. ［18］ Qi W, Chen J, Cheng X, et al. Targeting the Wnt-regulatory protein CTNNBIP1 by microRNA-214 enhances the stemness and self-renewal of cancer stem-like cells in lung adenocarcinomas［J］. Stem Cells, 2015, 33(12): 3423-3436. DOI: 10.1002/stem.2188. ［19］ Hassan KA, Wang L, Korkaya H, et al. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma［J］. Clin Cancer Res, 2013, 19(8): 1972-1980. DOI: 10.1158/1078-0432.CCR-12-0370. ［20］ Arasada RR, Amann JM, Rahman MA, et al. EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling［J］. Cancer Res, 2014, 74(19): 5572-5584. DOI: 10.1158/0008-5472.CAN-13-3724. ［21］ Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells［J］. PLoS One, 2009, 4(8): e6816. DOI: 10.1371/journal.pone.0006816. ［22］ Zhang S, Yang YL, Wang Y, et al. CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells［J］. J Exp Clin Cancer Res, 2014, 33: 93. DOI: 10.1186/s13046-014-0093-6. ［23］ Jiang N, Wang X, Xie X, et al. miR-326 is downstream of Sonic hedgehog signaling and regulates the expression of Gli2 and smoothened［J］. Am J Respir Cell Mol Biol, 2014, 51(2): 273-283. ［24］ Hu J, Qiu M, Jiang F, et al. MiR-145 regulates cancer stemlike properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells［J］. Tumour Biol, 2014, 35(9): 8953-8961. DOI: 10.1007/s13277-014-2158-8. ［25］ Han Z, Zhou X, Li S, et al. Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway［J］. Oncol Rep, 2017, 38(5): 3064-3070. DOI: 10.3892/or.2017.5938.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[3]	龚艳, 陈洪雷.微RNA调控卵巢癌顺铂耐药的机制研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 186-190.
[4]	贺嘉慧, 胡钦勇.基于GBD数据的中国和美国肺癌发病和死亡趋势及危险因素对比分析[J]. 国际肿瘤学杂志, 2024, 51(1): 29-36.
[5]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳.沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[6]	李雄安, 颜艳艳.丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192.
[7]	左小平, 刘晓川, 吴西强, 李周, 夏天, 刘国凤.老年早期肺癌患者经胸腔镜肺切除术后心律失常发生的危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(12): 711-716.
[8]	陈郁, 许华, 刘海, 陈士新.基于CT影像学特征的恶性肺纯磨玻璃结节患者病理分型预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(11): 655-660.
[9]	张万芳, 王尤, 苏晶, 陈刚, 周福祥.肺原发尤文肉瘤/原始神经外胚层瘤1例[J]. 国际肿瘤学杂志, 2023, 50(1): 62-64.
[10]	杨莎, 杨晓华, 王苏华, 薛晓燕, 徐俊.老年肺癌胸腔镜手术后下肢深静脉血栓的危险因素分析及预测模型的建立和验证[J]. 国际肿瘤学杂志, 2022, 49(9): 532-536.
[11]	王津, 张耀圣, 孙婷婷, 王丹, 胡乃东.以前胸壁聚集性多发蕈状肿物为表现的肺腺鳞状细胞癌皮肤转移1例[J]. 国际肿瘤学杂志, 2022, 49(9): 575-576.
[12]	陈煌婧, 朱鹏飞, 张晴, 陈桂芳, 杨春林, 何英.超声造影和CT引导下经皮穿刺活检在周围型肺肿块诊断中临床价值的比较[J]. 国际肿瘤学杂志, 2022, 49(8): 459-463.
[13]	蔡刚祥, 李境, 许斌.肺癌新辅助免疫治疗研究进展[J]. 国际肿瘤学杂志, 2022, 49(6): 366-370.
[14]	韩丛丛, 付帅, 谢超, 张建军, 张秋景, 祝情情, 刘杰.吉非替尼、培美曲塞和贝伐珠单抗一线治疗EGFR突变晚期肺腺癌的有效性和安全性[J]. 国际肿瘤学杂志, 2022, 49(6): 376-379.
[15]	王永洪, 何弢, 李星, 罗启余, 王乔羽.信迪利单抗致晚期鳞状细胞肺癌患者致死性中毒性表皮坏死松解症1例[J]. 国际肿瘤学杂志, 2022, 49(6): 380-382.